Portal Vein Diameter on Routine Clinical CT: Establishing Normals and Disease Associations
Hartmann, K.; Beeche, C.; Judy, R.; DePietro, D. M.; Witschey, W. R.; Duda, J.; Gee, J.; Gade, T.; Penn Medicine Biobank, ; Levin, M.; Damrauer, S. M.
Show abstract
PurposePortal hypertension, a major complication of chronic liver disease, leads to significant morbidity and mortality. While portal vein diameter measured on imaging has long been proposed as a non-invasive marker of portal hypertension, normative CT-based reference values and population-level associations remain incompletely characterized. Here, we aim to define contemporary reference values for portal vein diameter on clinically obtained CT and evaluate its associations with demographic, clinical, and imaging factors, as well as its diagnostic performance for portal hypertension. MethodsWe conducted a retrospective analysis of 20,225 clinically obtained CT scans at a single academic medical center. The main portal vein was automatically segmented using Total Segmentator, and maximum diameter extracted using the Vascular Modeling Toolkit. Associations with demographic and imaging factors were evaluated using linear mixed-effects models; prevalent liver disease and portal hypertension using logistic regression; risk of incident ascites and esophageal varices among participants with liver disease using Cox regression; and invasive hepatic venous pressures using correlation analysis and linear regression. ResultsThe mean portal vein diameter was 12.4 mm (95% CI, 12.37-12.45). Larger diameter was independently associated with male sex (+1.4 mm), higher BMI (+0.11 mm/kg/m2), greater height (+0.04 mm/cm), and older age (+0.05 mm/10 years) (all p <0.001), and was substantially larger on contrast-enhanced abdomen/pelvis CT (+2.4 mm, p <0.001). Each 1-mm increase in portal vein diameter was associated with higher odds of prevalent liver disease (OR 1.06; 95% CI, 1.04-1.08) and portal hypertension (OR 1.18; 95% CI, 1.12-1.28). Among individuals with liver disease, greater diameter predicted higher risk of incident esophageal varices (baseline diameter HR 1.50; 95% CI, 1.14-2.08) and ascites (HR per mm increase in diameter 1.06; 95% CI, 1.003-1.12). However, portal vein diameter demonstrated weak to no association with invasively measured hepatic venous pressures. ConclusionIn this large, EHR-linked imaging cohort, the mean portal vein diameter on CT was 12.4 mm and varied with demographic and imaging factors. Larger diameter was associated with liver disease, portal hypertension, and subsequent development of varices and ascites, supporting use of portal vein diameter as a pragmatic screening or enrichment tool within multimodal clinical frameworks. Key ResultsO_LIMean portal vein diameter on routine clinical CT was 12.4 mm (95% CI, 12.37-12.45) and varied with sex, height, BMI, exam type, contrast use, and clinical setting. C_LIO_LIEach 1-mm increase in portal vein diameter was associated with higher odds of prevalent liver disease (OR 1.06) and portal hypertension (OR 1.18). C_LIO_LIAmong individuals with liver disease, larger portal vein diameter predicted higher risk of incident esophageal varices and ascites, independent of demographic and imaging factors. C_LI
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Prediction of clinically relevant postoperative pancreatic fistula using radiomic features and preoperative data 91%
- Diet-induced rewiring of the Wnt gene regulatory network connects aberrant splicing to fatty liver and liver cancer in DIAMOND mice 90%
- Opportunistic Assessment of Ischemic Heart Disease Risk Using Abdominopelvic Computed Tomography and Medical Record Data: a Multimodal Explainable Artificial Intelligence Approach 90%
Similar papers in this journal
Similar papers in this journal
- DoUble resin Casting micro computed Tomography (DUCT) reveals biliary and vascular pathology in a mouse model of Alagille syndrome 93%
- Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis 91%
- β-Catenin-NFκB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction 91%
Similar papers in this journal
- Pre- and Post-Portosystemic Shunt Placement Metabolomics Reveal Molecular Signatures for the Development of Hepatic Encephalopathy 90%
- In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions 90%
- Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation 90%
Similar papers in this journal
- Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis – a comparison with T1-weighted black-blood imaging 89%
- Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis 87%
- COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.